ABSTRACT

Fact Sheet for Healthcare Providers: Emergency Use of the Prismaflex HF20 Set During the COVID-19 Pandemic   [open pdf - 148KB]

From the Document: "This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the Prismaflex HF20 Set to provide continuous renal replacement therapy (CRRT) to treat low weight (8-20 kg) and low blood volume patients who have acute renal failure, fluid overload, or both, and who cannot tolerate a larger extracorporeal circuit volume in an acute care environment during the COVID-19 [coronavirus disease 2019] pandemic."

Publisher:
Date:
2020-08-10
Series:
Copyright:
Public Domain
Retrieved From:
U.S. Food and Drug Administration: https://www.fda.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations